Association between systemic immune-inflammation index and ICU-acquired infection in critically Ill patients without infection: a competing risks analysis from a retrospective cohort

Abstract Background Healthcare-associated infections and their complications represent a predominant cause of morbidity and mortality in intensive care units (ICUs) globally. Several studies have reported that the systemic immune-inflammation index (SII) is associated with an increased risk of infection; however, its association with ICU-acquired infection (ICU-AI) remains unclear. We aimed to examine the association between SII and the subsequent risk of ICU-AI. Methods We conducted a retrospective cohort study using the MIMIC-IV database, including adult ICU patients without suspected infection at baseline. SII was calculated as platelet × neutrophil / lymphocyte count, based on values from the first 24 h of ICU admission. The primary outcome was ICU-AI, defined as suspected infection occurring after 48 h of ICU admission. Two competing risk regression models were employed to evaluate the association between SII and ICU-AI. Results Among the 5,459 patients included, 627 (11.5%) developed ICU-AI. Higher SII (per 1,000-unit) was independently associated with an increased risk of ICU-AI in both models: adjusted cause-specific hazard ratio (CSHR), 1.06 (95% CI, 1.03–1.08; p < 0.001) and subdistribution hazard ratio (SHR), 1.05 (95% CI, 1.03–1.07; p < 0.001). When analyzed by quartiles, a significant dose-response relationship was observed (p for trend < 0.001). Compared with patients in the lowest quartile (Q1, SII ≤ 594 × 10⁹/L), those in Q3 (SII 1125–2201 × 10⁹/L) and Q4 (SII ≥ 2202 × 10⁹/L) showed progressively higher risks of infection, with adjusted CSHR of 1.44 (95% CI 1.11–1.86) and 1.76 (95% CI 1.37–2.26), and adjusted SHR of 1.51 (95% CI 1.17–1.93) and 1.96 (95% CI 1.54–2.49), respectively. Time-to-event curves showed distinct and consistent cumulative risk trajectories across SII quartiles. Conclusion Elevated SII at ICU admission was independently associated with an increased risk of developing suspected secondary infection in infection-naïve critically ill patients.

Authors

Institutions

Publication Details

Journal
BMC Infectious Diseases
Published
2026-05-18
DOI
https://doi.org/10.1186/s12879-026-13568-0
Primary Topic
Inflammatory Biomarkers in Disease Prognosis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association between systemic immune-inflammation index and ICU-acquired infection in critically Ill patients without infection: a competing risks analysis from a retrospective cohort

Xianqing Meng, Dongqing Hu, Tian Liu, Yulian Ren et al.
BMC Infectious Diseases
Inflammatory Biomarkers in Disease Prognosis
article

Association between systemic immune-inflammation index and ICU-acquired infection in critically Ill patients without infection: a competing risks analysis from a retrospective cohort

Xianqing Meng, Dongqing Hu, Tian Liu, Yulian Ren, Xiao Ji, Lizhong Jing, Lu Li
article en

Abstract

Abstract Background Healthcare-associated infections and their complications represent a predominant cause of morbidity and mortality in intensive care units (ICUs) globally. Several studies have reported that the systemic immune-inflammation index (SII) is associated with an increased risk of infection; however, its association with ICU-acquired infection (ICU-AI) remains unclear. We aimed to examine the association between SII and the subsequent risk of ICU-AI. Methods We conducted a retrospective cohort study using the MIMIC-IV database, including adult ICU patients without suspected infection at baseline. SII was calculated as platelet × neutrophil / lymphocyte count, based on values from the first 24 h of ICU admission. The primary outcome was ICU-AI, defined as suspected infection occurring after 48 h of ICU admission. Two competing risk regression models were employed to evaluate the association between SII and ICU-AI. Results Among the 5,459 patients included, 627 (11.5%) developed ICU-AI. Higher SII (per 1,000-unit) was independently associated with an increased risk of ICU-AI in both models: adjusted cause-specific hazard ratio (CSHR), 1.06 (95% CI, 1.03–1.08; p < 0.001) and subdistribution hazard ratio (SHR), 1.05 (95% CI, 1.03–1.07; p < 0.001). When analyzed by quartiles, a significant dose-response relationship was observed (p for trend < 0.001). Compared with patients in the lowest quartile (Q1, SII ≤ 594 × 10⁹/L), those in Q3 (SII 1125–2201 × 10⁹/L) and Q4 (SII ≥ 2202 × 10⁹/L) showed progressively higher risks of infection, with adjusted CSHR of 1.44 (95% CI 1.11–1.86) and 1.76 (95% CI 1.37–2.26), and adjusted SHR of 1.51 (95% CI 1.17–1.93) and 1.96 (95% CI 1.54–2.49), respectively. Time-to-event curves showed distinct and consistent cumulative risk trajectories across SII quartiles. Conclusion Elevated SII at ICU admission was independently associated with an increased risk of developing suspected secondary infection in infection-naïve critically ill patients.

BMC Infectious Diseases
Shandong University of Traditional Chinese Medicine (CN), Shandong Provincial Hospital (CN), Affiliated Hospital of Shandong University of Traditional Chinese Medicine (CN)
Medical and Health Science and Technology Development Project of Shandong Province
Good health and well-being
Openalex Percentile: Top 7%
Inflammatory Biomarkers in Disease Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.